Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MADS MEJNERTSEN / REG. BESLAGSMED ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.1% 2.1%   Bankruptcy risk   17.7% 6.8% 5.9% 6.4% 6.3% 7.8% 21.5% 21.2%   Credit score (0-100)   9 36 39 36 37 31 5 5   Credit rating   B BBB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   2,017 1,714 0 0 0 0 0 0   Gross profit   1,421 1,103 964 841 945 1,169 0.0 0.0   EBITDA   249 130 105 8.9 48.1 244 0.0 0.0   EBIT   190 54.8 20.9 -77.0 -39.9 160 0.0 0.0   Pre-tax profit (PTP)   162.5 34.8 3.6 -93.6 -61.0 131.3 0.0 0.0   Net earnings   121.8 20.8 -1.7 -76.8 -51.6 88.4 0.0 0.0   Pre-tax profit without non-rec. items   163 34.8 3.6 -93.6 -61.0 131 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   146 370 285 217 129 45.0 0.0 0.0   Shareholders equity total   193 214 212 135 83.7 172 47.1 47.1   Interest-bearing liabilities   0.0 245 0.0 133 56.2 0.0 0.0 0.0   Balance sheet total (assets)   584 797 706 541 433 566 47.1 47.1   Net Debt   -121 239 -114 126 49.7 -93.0 -47.1 -47.1     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   2,017 1,714 0 0 0 0 0 0   Net sales growth   -11.2% -15.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,421 1,103 964 841 945 1,169 0.0 0.0   Gross profit growth   -12.4% -22.4% -12.6% -12.7% 12.4% 23.7% -100.0% 0.0%   Employees   3 2 2 2 2 2 0 0   Employee growth %   0.0% -33.3% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   584 797 706 541 433 566 47 47   Balance sheet change%   -17.3% 36.5% -11.4% -23.3% -20.1% 30.9% -91.7% 0.0%   Added value   190.1 54.8 20.9 -77.0 -39.9 159.8 0.0 0.0   Added value %   9.4% 3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -83 148 -169 -154 -176 -169 -45 0   Net sales trend   -2.0 -3.0 -4.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   12.4% 7.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   9.4% 3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.4% 5.0% 2.2% -9.2% -4.2% 13.7% 0.0% 0.0%   Net Earnings %   6.0% 1.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   9.0% 5.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   8.1% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   29.5% 7.9% 2.8% -12.4% -8.2% 32.0% 0.0% 0.0%   ROI %   66.9% 14.6% 5.4% -27.2% -17.3% 96.6% 0.0% 0.0%   ROE %   92.2% 10.2% -0.8% -44.2% -47.2% 69.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   33.1% 26.8% 30.1% 25.0% 19.4% 30.4% 100.0% 100.0%   Relative indebtedness %   17.3% 30.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   11.3% 30.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -48.6% 183.4% -108.2% 1,416.8% 103.1% -38.1% 0.0% 0.0%   Gearing %   0.0% 114.7% 0.0% 98.2% 67.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   23.0% 16.3% 14.1% 25.0% 22.3% 101.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.6 0.7 0.6 0.3 0.8 0.0 0.0   Current Ratio   1.3 0.8 1.0 0.9 0.9 1.3 0.0 0.0   Cash and cash equivalent   121.1 6.5 113.9 6.5 6.5 93.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   15.3 44.8 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   30.9 34.1 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   21.7% 24.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   89.4 -99.8 -22.0 -47.0 -27.0 127.1 0.0 0.0   Net working capital %   4.4% -5.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   672 857 0 0 0 0 0 0   Added value / employee   63 27 10 -38 -20 80 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   83 65 53 4 24 122 0 0   EBIT / employee   63 27 10 -38 -20 80 0 0   Net earnings / employee   41 10 -1 -38 -26 44 0 0